Research ArticleResearchPatient Education

A personalized diet showed more durable IBS symptom improvement than low-FODMAP care

Gut microbes (PubMed)Aug 20, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In a hypothesis-generating follow-up of a multicenter randomized trial, a microbiome-guided personalized diet showed more durable IBS symptom improvement over 12 months than a standard low-FODMAP diet.

What NurseJet pulled from the source

Both diets reduced IBS symptom scores after the six-week intervention. At 12 months without further dietary intervention, responder rates were 62.5% with the personalized diet and 34.5% with low-FODMAP care, while quality-of-life and anxiety and depression trajectories also favored personalization.

Why this matters for nurses

Diet education is common in IBS care, but restrictive plans can be difficult to sustain. The study suggests that individualized dietary guidance may produce more durable symptom control, while its exploratory design does not justify substituting an unvalidated microbiome service for established clinical nutrition care.

Bedside takeaway

Personalized dietary care showed a more durable IBS symptom signal, but larger long-term trials are needed before practice change.

How This Applies in Practice

Use this when: Teaching or reconciling a dietary plan for an adult with IBS who is using a low-FODMAP or individualized nutrition strategy.

On your shift

Document the current diet, symptom response, unintended restriction, weight change, and access to qualified nutrition support.
Reinforce the clinician-directed plan for restriction, reintroduction, and follow-up rather than adding unapproved exclusions.
Escalate persistent symptoms, nutritional risk, or worsening anxiety around food through the established care pathway.

Keep in mind: The personalized approach remains hypothesis-generating and should not be equated with any commercial test. Follow the nutrition plan, facility policy, and provider orders.

Key takeaways

Both randomized diet groups improved during the initial six-week intervention.
Personalized-diet symptom improvement was maintained at six and 12 months, while low-FODMAP benefits regressed by 12 months.
At 12 months, IBS symptom-score responder rates were 62.5% versus 34.5%, an absolute difference of 28 percentage points.
The authors describe the follow-up as hypothesis-generating and call for larger trials powered for long-term outcomes.

Practice implications

Ask what dietary plan the patient is following, whether symptoms and nutrition are being monitored, and whether a qualified clinician or dietitian is guiding restriction and reintroduction. Avoid presenting commercial microbiome personalization as established standard care on the basis of this follow-up alone.

Limitations & cautions

This open-label follow-up included participants who completed the initial six-week intervention, and the abstract does not report the randomized sample size. No further dietary intervention was delivered during follow-up, and the authors characterize the results as hypothesis-generating.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Gut microbes (PubMed)

Gut microbes (PubMed). Long-term microbiome and clinical effects of a microbiome-guided personalized diet versus low-FODMAP diet in irritable bowel syndrome: A 12-month follow-up randomized controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42623122/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Renal failure (PubMed)Sep 7, 2026Research Article

A single-center retrospective cohort found that approximately one quarter of laboratory-defined acute kidney injury cases on internal medicine wards were not documented, particularly when maximal creatinine was lower.

Med-SurgAI summaryReview source

Research ArticleResearchQuality ImprovementAI summary · original source linked below

Among 161 adult hospitalizations meeting serum-creatinine criteria for acute kidney injury, 39 cases (24.2%) were undocumented. Length of stay and in-hospital mortality did not differ significantly by documentation status.

Key takeaways

In the 149 hospitalizations with a demonstrable creatinine change, 33 cases (22.1%) were undocumented.
Higher maximal creatinine was associated with lower adjusted odds of underdocumentation.
The study did not test whether a detection or documentation intervention improves care or outcomes.

Why this matters on shift

A smaller creatinine rise may receive less attention even when it meets the study's laboratory definition of acute kidney injury, which can affect how renal risk is communicated across the inpatient team.

Bedside takeaway

Trend ordered renal-function results and communicate clinically important changes through local escalation and documentation workflows.

Nursing implications

Trend ordered renal-function results and communicate clinically important changes through the care team according to local escalation and documentation workflows.

Limitations & cautions

Abstract-only summary. This was a retrospective, single-center study of 161 hospitalizations; urine-output criteria and reliable preadmission creatinine values were unavailable, and the reference creatinine method may affect case classification.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Renal failure (PubMed). Underdocumentation of laboratory-defined acute kidney injury in internal medicine wards: a retrospective cohort study.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

European heart journal (PubMed)Sep 6, 2026Research Article

In the pragmatic TARGET-D randomized trial, vitamin D dosing titrated to a serum target did not significantly reduce the composite of death, recurrent myocardial infarction, heart-failure hospitalization, or stroke after myocardial infarction.

Telemetry Med-SurgAI summaryReview source

Research ArticleResearchMedication SafetyPatient EducationAI summary · original source linked below

Among 630 participants followed for an average of 4.2 years, major cardiovascular events occurred in 15.7% with targeted vitamin D management and 18.4% with usual care (hazard ratio 0.85, 95% CI 0.58 to 1.24; P=0.40).

Key takeaways

At baseline, 87% of participants had a 25-hydroxyvitamin D level of 40 ng/mL or lower.
The primary composite outcome and the individual outcomes of death, heart-failure hospitalization, and stroke were not significantly different.
A lower recurrent-MI rate was a secondary finding and should not override the nonsignificant primary result.

Why this matters on shift

The trial cautions against presenting targeted vitamin D supplementation as a proven strategy for reducing major cardiovascular events after myocardial infarction.

Bedside takeaway

Present vitamin D as prescribed supplementation, not as a replacement for established post-MI secondary prevention.

Nursing implications

Reinforce the prescribed secondary-prevention plan and avoid implying that vitamin D replaces therapies with established post-MI benefit.

Limitations & cautions

Abstract-only summary. The trial included 630 participants, 78.1% were men, the primary confidence interval included benefit and no benefit, and individual secondary outcomes were not the primary endpoint.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

European heart journal (PubMed). Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of the American Medical Directors Association (PubMed)Sep 5, 2026Research Article

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

Geriatrics Med-SurgAI summaryReview source

Research ArticleResearchInfection ControlAI summary · original source linked below

Among 3,195 residents at 15 nursing homes, 526 suspected acute respiratory-infection episodes were recorded and a virus was identified in 291. Influenza A was associated with delayed recovery, oxygen use, and threefold secondary-bacterial-pneumonia risk; hMPV was linked to fourfold more time in bed.

Key takeaways

SARS-CoV-2, influenza A, rhinovirus or enterovirus, and RSV were the most frequently identified viruses.
hMPV and RSV tended to have higher odds of moderate or severe disease.
Virus-specific patterns were associations from a cohort, not randomized comparisons.

Why this matters on shift

Frailty can amplify respiratory-infection consequences, and the causative virus may help anticipate recovery, oxygen, mobility, and secondary-infection needs.

Bedside takeaway

Trend oxygen needs, mobility, recovery, and secondary-pneumonia signs during nursing-home respiratory infections.

Nursing implications

During outbreaks or suspected infection, trend oxygen needs, mobility and time in bed, recovery, and signs of bacterial pneumonia according to facility protocols.

Limitations & cautions

Abstract-only summary. Data came from 15 Dutch nursing homes, the overall suspected-infection risk estimate was imprecise, and virus-outcome comparisons may be affected by confounding and small subgroup counts.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of the American Medical Directors Association (PubMed). Clinical Impact of Acute Respiratory Virus Infections in Nursing Home Residents.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

One in four laboratory-defined AKI cases went undocumented on medicine wards

Targeted vitamin D did not significantly reduce major cardiovascular events after MI

Influenza and hMPV carried substantial illness burden in nursing home residents